Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Aneurysm | 65 | 2024 | 1285 | 9.240 |
Why?
|
Embolization, Therapeutic | 50 | 2024 | 1418 | 6.650 |
Why?
|
Endovascular Procedures | 42 | 2024 | 2183 | 3.870 |
Why?
|
Aneurysm, Ruptured | 21 | 2024 | 464 | 3.320 |
Why?
|
Takotsubo Cardiomyopathy | 3 | 2021 | 123 | 1.910 |
Why?
|
Neurosurgical Procedures | 21 | 2024 | 2072 | 1.810 |
Why?
|
Stents | 30 | 2024 | 3179 | 1.780 |
Why?
|
Cerebral Arteries | 5 | 2017 | 490 | 1.560 |
Why?
|
Carotid Artery, Internal | 12 | 2024 | 445 | 1.460 |
Why?
|
Hematoma, Subdural, Chronic | 7 | 2024 | 95 | 1.400 |
Why?
|
Subarachnoid Hemorrhage | 9 | 2022 | 1033 | 1.390 |
Why?
|
Cavernous Sinus | 3 | 2017 | 123 | 1.290 |
Why?
|
Cerebral Angiography | 19 | 2024 | 1281 | 1.090 |
Why?
|
Brain Ischemia | 9 | 2021 | 3049 | 1.030 |
Why?
|
Stroke | 14 | 2023 | 9758 | 1.030 |
Why?
|
Neurosurgery | 7 | 2024 | 679 | 1.020 |
Why?
|
Vertebral Artery | 8 | 2024 | 185 | 1.000 |
Why?
|
Cerebral Revascularization | 9 | 2024 | 259 | 0.980 |
Why?
|
Thromboembolism | 5 | 2024 | 995 | 0.930 |
Why?
|
Anterior Cerebral Artery | 1 | 2024 | 50 | 0.910 |
Why?
|
Vein of Galen Malformations | 2 | 2018 | 58 | 0.910 |
Why?
|
Craniotomy | 8 | 2023 | 741 | 0.890 |
Why?
|
Ophthalmic Artery | 1 | 2023 | 58 | 0.870 |
Why?
|
Heart Arrest, Induced | 2 | 2018 | 358 | 0.850 |
Why?
|
Carotid Stenosis | 4 | 2015 | 860 | 0.800 |
Why?
|
Moyamoya Disease | 5 | 2024 | 265 | 0.780 |
Why?
|
Cerebrovascular Disorders | 5 | 2023 | 1474 | 0.750 |
Why?
|
Arteriovenous Fistula | 3 | 2023 | 319 | 0.750 |
Why?
|
Thrombectomy | 4 | 2021 | 705 | 0.750 |
Why?
|
Physiological Phenomena | 1 | 2021 | 18 | 0.740 |
Why?
|
Carotid Artery Injuries | 2 | 2019 | 96 | 0.710 |
Why?
|
Hematoma, Subdural, Acute | 2 | 2011 | 16 | 0.700 |
Why?
|
Central Nervous System Vascular Malformations | 4 | 2023 | 140 | 0.660 |
Why?
|
Treatment Outcome | 66 | 2024 | 64685 | 0.650 |
Why?
|
Platelet Aggregation Inhibitors | 9 | 2024 | 2751 | 0.590 |
Why?
|
Meningioma | 4 | 2014 | 1218 | 0.580 |
Why?
|
Platelet Function Tests | 4 | 2024 | 271 | 0.560 |
Why?
|
Retrospective Studies | 57 | 2024 | 80647 | 0.530 |
Why?
|
Compartment Syndromes | 1 | 2018 | 159 | 0.510 |
Why?
|
Vasospasm, Intracranial | 2 | 2021 | 215 | 0.500 |
Why?
|
Electrodes | 1 | 2018 | 614 | 0.500 |
Why?
|
Adenosine | 2 | 2018 | 808 | 0.500 |
Why?
|
Atlanto-Occipital Joint | 1 | 2015 | 33 | 0.490 |
Why?
|
Atlanto-Axial Joint | 1 | 2015 | 60 | 0.480 |
Why?
|
Temporal Arteries | 3 | 2024 | 154 | 0.480 |
Why?
|
Conscious Sedation | 1 | 2018 | 532 | 0.450 |
Why?
|
Humans | 141 | 2024 | 761596 | 0.450 |
Why?
|
Cranial Sinuses | 1 | 2013 | 68 | 0.440 |
Why?
|
Intracranial Arteriovenous Malformations | 3 | 2024 | 366 | 0.430 |
Why?
|
Cerebrovascular Circulation | 4 | 2019 | 2727 | 0.410 |
Why?
|
Aneurysm | 3 | 2023 | 337 | 0.410 |
Why?
|
Aged | 52 | 2024 | 169310 | 0.400 |
Why?
|
World War I | 1 | 2011 | 14 | 0.390 |
Why?
|
Postoperative Complications | 14 | 2024 | 15633 | 0.390 |
Why?
|
Carotid-Cavernous Sinus Fistula | 2 | 2023 | 37 | 0.380 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 840 | 0.380 |
Why?
|
Monitoring, Intraoperative | 1 | 2018 | 942 | 0.380 |
Why?
|
Motion | 1 | 2015 | 779 | 0.380 |
Why?
|
Meningeal Arteries | 4 | 2024 | 68 | 0.380 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2578 | 0.380 |
Why?
|
Wounds, Nonpenetrating | 1 | 2017 | 807 | 0.370 |
Why?
|
Hematoma, Subdural | 1 | 2011 | 127 | 0.360 |
Why?
|
Propensity Score | 6 | 2024 | 1913 | 0.360 |
Why?
|
Fundoplication | 1 | 2011 | 144 | 0.350 |
Why?
|
Carotid Artery Diseases | 4 | 2023 | 877 | 0.350 |
Why?
|
Hypopituitarism | 2 | 2017 | 250 | 0.350 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1667 | 0.350 |
Why?
|
Spinal Cord Diseases | 2 | 2023 | 292 | 0.350 |
Why?
|
Skull Base Neoplasms | 2 | 2012 | 270 | 0.340 |
Why?
|
Brain Injuries | 2 | 2012 | 2054 | 0.340 |
Why?
|
Dura Mater | 1 | 2011 | 290 | 0.340 |
Why?
|
Female | 74 | 2024 | 392705 | 0.330 |
Why?
|
Military Medicine | 1 | 2011 | 184 | 0.330 |
Why?
|
Radiosurgery | 3 | 2024 | 1342 | 0.320 |
Why?
|
Computer-Aided Design | 1 | 2011 | 300 | 0.320 |
Why?
|
Blood Vessel Prosthesis | 5 | 2023 | 951 | 0.320 |
Why?
|
Middle Aged | 58 | 2024 | 220921 | 0.310 |
Why?
|
Male | 68 | 2024 | 360846 | 0.310 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2008 | 59 | 0.300 |
Why?
|
Pituitary Gland | 1 | 2011 | 635 | 0.300 |
Why?
|
Middle Cerebral Artery | 2 | 2020 | 275 | 0.280 |
Why?
|
Posterior Cerebral Artery | 2 | 2024 | 35 | 0.280 |
Why?
|
Vascular Diseases | 1 | 2015 | 1161 | 0.270 |
Why?
|
Collateral Circulation | 2 | 2024 | 294 | 0.270 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2012 | 740 | 0.270 |
Why?
|
Endarterectomy, Carotid | 1 | 2011 | 555 | 0.260 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 2018 | 141 | 0.260 |
Why?
|
Adult | 47 | 2024 | 221210 | 0.260 |
Why?
|
Thrombolytic Therapy | 2 | 2011 | 2064 | 0.250 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 981 | 0.250 |
Why?
|
Fibrinolytic Agents | 3 | 2019 | 2084 | 0.240 |
Why?
|
Arteriovenous Malformations | 3 | 2017 | 396 | 0.230 |
Why?
|
Meningeal Neoplasms | 1 | 2013 | 1248 | 0.230 |
Why?
|
Physicians | 1 | 2022 | 4591 | 0.230 |
Why?
|
Magnetic Resonance Angiography | 4 | 2017 | 1432 | 0.230 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1779 | 0.230 |
Why?
|
Vertebral Artery Dissection | 1 | 2024 | 51 | 0.230 |
Why?
|
Cerebellum | 1 | 2011 | 1501 | 0.220 |
Why?
|
Accidental Falls | 1 | 2011 | 1068 | 0.220 |
Why?
|
Aortic Valve Stenosis | 1 | 2015 | 2001 | 0.210 |
Why?
|
Checklist | 1 | 2010 | 827 | 0.210 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1213 | 0.210 |
Why?
|
Aged, 80 and over | 17 | 2024 | 58984 | 0.210 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1882 | 0.200 |
Why?
|
Follow-Up Studies | 13 | 2024 | 39106 | 0.200 |
Why?
|
Off-Label Use | 1 | 2024 | 185 | 0.200 |
Why?
|
Emergencies | 1 | 2008 | 1217 | 0.190 |
Why?
|
Wind | 1 | 2021 | 42 | 0.180 |
Why?
|
Platelet Aggregation | 1 | 2024 | 771 | 0.180 |
Why?
|
After-Hours Care | 1 | 2021 | 102 | 0.180 |
Why?
|
Oxygen | 1 | 2012 | 4227 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 846 | 0.180 |
Why?
|
Surgical Instruments | 3 | 2018 | 383 | 0.180 |
Why?
|
General Surgery | 1 | 2011 | 1692 | 0.170 |
Why?
|
Reperfusion | 1 | 2020 | 271 | 0.170 |
Why?
|
Microsurgery | 4 | 2024 | 795 | 0.170 |
Why?
|
Equipment Design | 3 | 2021 | 3511 | 0.160 |
Why?
|
Aspirin | 4 | 2024 | 3133 | 0.160 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2019 | 42 | 0.160 |
Why?
|
Drug Resistance | 1 | 2024 | 1596 | 0.150 |
Why?
|
Dimethyl Sulfoxide | 1 | 2019 | 251 | 0.150 |
Why?
|
Intracranial Hemorrhages | 2 | 2015 | 822 | 0.150 |
Why?
|
Consensus | 2 | 2024 | 3124 | 0.140 |
Why?
|
Switzerland | 2 | 2008 | 324 | 0.140 |
Why?
|
Sphenoid Sinus | 1 | 2017 | 99 | 0.140 |
Why?
|
Matrix Metalloproteinases | 1 | 2019 | 393 | 0.140 |
Why?
|
Length of Stay | 3 | 2024 | 6426 | 0.140 |
Why?
|
Blepharoptosis | 2 | 2020 | 144 | 0.130 |
Why?
|
Rupture | 1 | 2017 | 443 | 0.130 |
Why?
|
Skull Base | 2 | 2023 | 292 | 0.130 |
Why?
|
Coagulants | 1 | 2015 | 45 | 0.130 |
Why?
|
Young Adult | 13 | 2024 | 59260 | 0.130 |
Why?
|
Interleukin-6 | 2 | 2022 | 3208 | 0.130 |
Why?
|
Mucormycosis | 2 | 2013 | 103 | 0.120 |
Why?
|
Angiography, Digital Subtraction | 4 | 2019 | 335 | 0.120 |
Why?
|
Intracranial Thrombosis | 1 | 2015 | 108 | 0.120 |
Why?
|
Myosin Heavy Chains | 1 | 2016 | 405 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 10 | 2019 | 20568 | 0.120 |
Why?
|
Cerebral Hemorrhage | 2 | 2019 | 2656 | 0.120 |
Why?
|
Cohort Studies | 10 | 2022 | 41495 | 0.110 |
Why?
|
Frontal Lobe | 1 | 2020 | 1420 | 0.110 |
Why?
|
Hepatic Artery | 1 | 2015 | 232 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 3 | 2017 | 4062 | 0.110 |
Why?
|
Equipment Failure | 1 | 2016 | 578 | 0.110 |
Why?
|
Arachnoid Cysts | 1 | 2014 | 61 | 0.110 |
Why?
|
Fibrous Dysplasia, Polyostotic | 1 | 2013 | 39 | 0.110 |
Why?
|
Brain Neoplasms | 2 | 2014 | 9032 | 0.110 |
Why?
|
Pineal Gland | 1 | 2014 | 158 | 0.110 |
Why?
|
Molecular Biology | 1 | 2017 | 576 | 0.110 |
Why?
|
Temporal Lobe | 1 | 2020 | 1695 | 0.110 |
Why?
|
Central Nervous System Infections | 1 | 2013 | 61 | 0.110 |
Why?
|
Aneurysm, False | 1 | 2015 | 255 | 0.100 |
Why?
|
Skull Neoplasms | 1 | 2013 | 173 | 0.100 |
Why?
|
Facial Bones | 1 | 2013 | 208 | 0.100 |
Why?
|
Angioplasty | 2 | 2013 | 355 | 0.100 |
Why?
|
Video Recording | 1 | 2017 | 967 | 0.100 |
Why?
|
Vasculitis | 1 | 2016 | 521 | 0.100 |
Why?
|
Adolescent | 11 | 2024 | 88326 | 0.100 |
Why?
|
Injections, Intra-Arterial | 1 | 2011 | 182 | 0.100 |
Why?
|
Streptokinase | 1 | 2011 | 186 | 0.100 |
Why?
|
Principle-Based Ethics | 1 | 2011 | 11 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 10 | 2024 | 36426 | 0.100 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5493 | 0.090 |
Why?
|
Subdural Effusion | 1 | 2011 | 19 | 0.090 |
Why?
|
Glasgow Coma Scale | 2 | 2016 | 580 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 2 | 2019 | 1164 | 0.090 |
Why?
|
Students, Medical | 1 | 2024 | 1936 | 0.090 |
Why?
|
Paralysis | 1 | 2012 | 250 | 0.090 |
Why?
|
Diplopia | 1 | 2012 | 214 | 0.090 |
Why?
|
Curriculum | 1 | 2024 | 3743 | 0.090 |
Why?
|
Patient Positioning | 1 | 2013 | 326 | 0.090 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2011 | 325 | 0.090 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2011 | 49 | 0.090 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 957 | 0.090 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2011 | 134 | 0.090 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2017 | 1725 | 0.090 |
Why?
|
Drainage | 2 | 2023 | 1157 | 0.090 |
Why?
|
Infant | 5 | 2018 | 36193 | 0.080 |
Why?
|
Spinal Cord | 1 | 2018 | 1819 | 0.080 |
Why?
|
Decompressive Craniectomy | 1 | 2010 | 76 | 0.080 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2011 | 170 | 0.080 |
Why?
|
Blood Coagulation | 1 | 2015 | 1154 | 0.080 |
Why?
|
Injections, Intravenous | 1 | 2011 | 1379 | 0.080 |
Why?
|
Muscle Weakness | 1 | 2012 | 412 | 0.080 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 491 | 0.080 |
Why?
|
Skull | 1 | 2013 | 818 | 0.080 |
Why?
|
Child | 8 | 2023 | 80158 | 0.080 |
Why?
|
Germany | 1 | 2011 | 875 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2017 | 1323 | 0.080 |
Why?
|
Brain | 3 | 2012 | 27121 | 0.080 |
Why?
|
Oximetry | 1 | 2012 | 459 | 0.080 |
Why?
|
History, 19th Century | 1 | 2011 | 720 | 0.080 |
Why?
|
Communication | 1 | 2023 | 3875 | 0.080 |
Why?
|
Anticoagulants | 3 | 2023 | 4812 | 0.080 |
Why?
|
Yugoslavia | 1 | 2008 | 23 | 0.080 |
Why?
|
Hydrocephalus | 1 | 2015 | 764 | 0.080 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 847 | 0.080 |
Why?
|
Science | 1 | 2011 | 239 | 0.080 |
Why?
|
Asymptomatic Diseases | 1 | 2011 | 588 | 0.080 |
Why?
|
Regional Blood Flow | 1 | 2012 | 1496 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3246 | 0.080 |
Why?
|
Retreatment | 2 | 2020 | 598 | 0.080 |
Why?
|
Glasgow Outcome Scale | 1 | 2008 | 104 | 0.070 |
Why?
|
Medical Errors | 1 | 2016 | 1263 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 2011 | 589 | 0.070 |
Why?
|
Laminectomy | 2 | 2023 | 225 | 0.070 |
Why?
|
Time Factors | 5 | 2021 | 39969 | 0.070 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1371 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2366 | 0.070 |
Why?
|
Brain Mapping | 1 | 2022 | 6635 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3290 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2163 | 0.070 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2010 | 485 | 0.070 |
Why?
|
Blood Platelets | 1 | 2017 | 2479 | 0.070 |
Why?
|
Operating Rooms | 1 | 2013 | 789 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1388 | 0.070 |
Why?
|
Neoplasm, Residual | 1 | 2011 | 1008 | 0.060 |
Why?
|
Neurilemmoma | 1 | 2011 | 526 | 0.060 |
Why?
|
Tomography Scanners, X-Ray Computed | 2 | 2017 | 173 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1784 | 0.060 |
Why?
|
Child, Preschool | 5 | 2023 | 42232 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3242 | 0.060 |
Why?
|
Hospital Costs | 2 | 2021 | 947 | 0.060 |
Why?
|
Skin Diseases, Genetic | 1 | 2024 | 49 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4244 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2015 | 2330 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2015 | 4471 | 0.050 |
Why?
|
Risk Factors | 8 | 2024 | 74213 | 0.050 |
Why?
|
History, 20th Century | 1 | 2011 | 2767 | 0.050 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2004 | 138 | 0.050 |
Why?
|
Vascular Surgical Procedures | 2 | 2024 | 1489 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2022 | 127 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8633 | 0.050 |
Why?
|
Silk | 1 | 2022 | 90 | 0.050 |
Why?
|
Genes, APC | 1 | 2002 | 145 | 0.050 |
Why?
|
Founder Effect | 1 | 2002 | 186 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2008 | 1475 | 0.050 |
Why?
|
Orbit | 1 | 2024 | 457 | 0.050 |
Why?
|
Disease Management | 1 | 2011 | 2508 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12059 | 0.050 |
Why?
|
Learning Curve | 1 | 2022 | 230 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2008 | 1836 | 0.050 |
Why?
|
Ticlopidine | 2 | 2017 | 730 | 0.040 |
Why?
|
Clinical Competence | 1 | 2016 | 4793 | 0.040 |
Why?
|
Jews | 1 | 2002 | 356 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2005 | 941 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1096 | 0.040 |
Why?
|
Device Approval | 1 | 2021 | 163 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1725 | 0.040 |
Why?
|
Arteries | 1 | 2024 | 1123 | 0.040 |
Why?
|
Enbucrilate | 1 | 2019 | 30 | 0.040 |
Why?
|
Cyanoacrylates | 1 | 2019 | 46 | 0.040 |
Why?
|
North America | 1 | 2022 | 1276 | 0.040 |
Why?
|
Ophthalmoplegia | 1 | 2020 | 168 | 0.040 |
Why?
|
Neck | 1 | 2023 | 734 | 0.040 |
Why?
|
Emergency Medical Services | 2 | 2020 | 1923 | 0.040 |
Why?
|
Vascular Malformations | 1 | 2024 | 468 | 0.040 |
Why?
|
Recurrence | 3 | 2020 | 8466 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2004 | 882 | 0.040 |
Why?
|
Models, Animal | 1 | 2005 | 2112 | 0.040 |
Why?
|
Treatment Failure | 1 | 2024 | 2643 | 0.040 |
Why?
|
Seizures | 1 | 2011 | 2957 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6241 | 0.040 |
Why?
|
Activin Receptors, Type II | 1 | 2018 | 123 | 0.040 |
Why?
|
Neck Injuries | 1 | 2019 | 160 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 54423 | 0.040 |
Why?
|
Patient Discharge | 2 | 2021 | 3443 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2017 | 150 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2023 | 980 | 0.030 |
Why?
|
Age Factors | 2 | 2011 | 18399 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2024 | 1349 | 0.030 |
Why?
|
Epistaxis | 1 | 2017 | 112 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2017 | 168 | 0.030 |
Why?
|
Joint Instability | 1 | 2024 | 801 | 0.030 |
Why?
|
Bites and Stings | 1 | 2017 | 93 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1679 | 0.030 |
Why?
|
Rabbits | 1 | 2022 | 4772 | 0.030 |
Why?
|
Amputation, Traumatic | 1 | 2017 | 135 | 0.030 |
Why?
|
Utah | 1 | 2015 | 131 | 0.030 |
Why?
|
Finger Injuries | 1 | 2017 | 145 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8002 | 0.030 |
Why?
|
Functional Laterality | 1 | 2022 | 2257 | 0.030 |
Why?
|
Encephalitis | 1 | 2019 | 440 | 0.030 |
Why?
|
Blood Pressure | 1 | 2011 | 8481 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10090 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7968 | 0.030 |
Why?
|
Polymers | 1 | 2022 | 1616 | 0.030 |
Why?
|
Animals | 7 | 2024 | 168475 | 0.030 |
Why?
|
Hyponatremia | 1 | 2017 | 279 | 0.030 |
Why?
|
Hematoma | 1 | 2019 | 767 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10212 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2008 | 3744 | 0.030 |
Why?
|
Iohexol | 1 | 2015 | 204 | 0.030 |
Why?
|
Craniocerebral Trauma | 1 | 2019 | 490 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8527 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2645 | 0.030 |
Why?
|
Angiography | 1 | 2019 | 1595 | 0.030 |
Why?
|
Hospitalization | 2 | 2024 | 10721 | 0.030 |
Why?
|
Papaverine | 1 | 2013 | 45 | 0.030 |
Why?
|
Vitamin K | 1 | 2015 | 318 | 0.030 |
Why?
|
Language | 1 | 2022 | 1543 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1664 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9280 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1814 | 0.030 |
Why?
|
Antifibrinolytic Agents | 1 | 2015 | 292 | 0.030 |
Why?
|
Prognosis | 2 | 2013 | 29629 | 0.020 |
Why?
|
Nasal Obstruction | 1 | 2013 | 160 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12973 | 0.020 |
Why?
|
Risk Assessment | 2 | 2023 | 23996 | 0.020 |
Why?
|
Hypesthesia | 1 | 2011 | 107 | 0.020 |
Why?
|
Device Removal | 1 | 2015 | 630 | 0.020 |
Why?
|
Facial Pain | 1 | 2011 | 120 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2548 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1242 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2012 | 516 | 0.020 |
Why?
|
Sacrum | 1 | 2011 | 276 | 0.020 |
Why?
|
United States | 3 | 2021 | 72340 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2013 | 973 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21355 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4021 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7396 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5293 | 0.020 |
Why?
|
Genetic Variation | 1 | 2002 | 6567 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11530 | 0.020 |
Why?
|
Temporal Bone | 1 | 2011 | 683 | 0.020 |
Why?
|
Vision Disorders | 1 | 2013 | 1088 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2280 | 0.020 |
Why?
|
Brain Edema | 1 | 2010 | 604 | 0.020 |
Why?
|
Headache | 1 | 2013 | 1256 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2017 | 9001 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13255 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14608 | 0.010 |
Why?
|
Internship and Residency | 1 | 2024 | 5882 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2013 | 1428 | 0.010 |
Why?
|
Mutation | 2 | 2018 | 30053 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2002 | 6938 | 0.010 |
Why?
|
Vitamin D | 1 | 2015 | 3303 | 0.010 |
Why?
|
Contrast Media | 1 | 2015 | 5307 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15843 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23447 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2004 | 916 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 2004 | 537 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7391 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26129 | 0.010 |
Why?
|
Israel | 1 | 2002 | 726 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8225 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 1068 | 0.010 |
Why?
|
Cerebral Infarction | 1 | 2004 | 983 | 0.010 |
Why?
|
Hemorrhage | 1 | 2010 | 3424 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26202 | 0.010 |
Why?
|
Swine | 1 | 2005 | 5915 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13510 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2005 | 5247 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 6965 | 0.010 |
Why?
|
Reoperation | 1 | 2004 | 4303 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 22176 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 29890 | 0.010 |
Why?
|
Hypertension | 1 | 2010 | 8540 | 0.010 |
Why?
|